US5895841014 - Common Stock
MERIDIAN BIOSCIENCE INC
NASDAQ:VIVO (1/30/2023, 8:27:46 PM)
After market: 33.99 +0.02 (+0.06%)33.97
0 (0%)
Meridian Bioscience, Inc. engages in the development, production, sale, and distribution of diagnostic products. The company is headquartered in Cincinnati, Ohio and currently employs 770 full-time employees. The firm is engaged in the development, manufacture, sale and distribution of diagnostic testing systems and kits, primarily for certain gastrointestinal and respiratory infectious diseases, and elevated blood lead levels; and the manufacture and distribution of bulk antigens, antibodies, immunoassay blocking reagents, specialized polymerase chain reaction (PCR) master mixes, and bioresearch reagents used by other diagnostic test manufacturers and researchers in immunological and molecular tests for human, animal, plant and environmental applications. The firm's segments include Diagnostics and Life Science. The Diagnostics segment consists of manufacturing operations for infectious disease products in Cincinnati, Ohio; Quebec City, Canada; and Modi'in, Israel. The Life Science segment consists of manufacturing operations in Memphis, Tennessee; Boca Raton, Florida; London, England; and Luckenwalde, Germany.
MERIDIAN BIOSCIENCE INC
3471 River Hills Dr
Cincinnati OHIO 45244
P: 15132713700.0
CEO: Jack Kenny
Employees: 770
Website: https://www.meridianbioscience.com/
/PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, and SD...
/PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced...
CINCINNATI, Nov. 22, 2022 /PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial results for the fourth quarter and fi...
Meridian Bioscience press release (VIVO): Q4 Non-GAAP EPS of $0.21.Revenue of $65.67M (-13.8% Y/Y).Diagnostics segment net revenues increased 14% year-over-year to $39.2...
This quartet of stocks has plenty of growth ahead and is already profitable.
Here you can normally see the latest stock twits on VIVO, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: